Chronic Disease Management

The chronic disease management market encompasses consumers with chronic, complex conditions such as chronic kidney disease, diabetes, and heart disease. The challenges faced in this market are often compounded by the need for social services and supports. For provider organizations and health systems managing consumers with chronic conditions, a significant challenge that remains is addressing the rising cost of care for this population. As a result, payers are focusing on reducing the spend by increasing integrated models of care coordination across medical, behavioral, pharmacy, and social support systems. These new market forces are creating strategic opportunities for provider organizations that are serving this population.


Editor's Picks

Wysa’s App For Adults With Chronic Pain Receives FDA Breakthrough Device Designation

On May 12, 2022, Wysa announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to its artificial intelligence (AI)-based cognitive behavioral therapy (CBT) app for adults with chronic musculoskeletal pain, who also have depression and/or anxiety. Chronic musculoskeletal pain is defined as pain lasting longer than three months. Wysa is a… Read

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!